Who is behind WikiPathways?
WikiPathways is run by people like you! Join our teams of reviewers, community editors and developers to maintain this public resource of pathway information.
Coordination
Architects: Responsible for roadmap planning, onboarding new developers, and setting best practices.
Community Coordinators: Responsible for reviewer coordination, organization of community meetings, educational material.
Reviewers
Help review pathway edits, monitor automated reports, or join the Reviewer Roster.
Egon Willighagen
View profile
Kristina Hanspers
View profile
Martina Summer-Kutmon
View profile
Alex Pico
View profile
Denise Slenter
View profile
Friederike Ehrhart
View profile
Daniela Digles
View profile
Susan Coort
View profile
Andra Waagmeester
View profile
Elisson nl
View profile
Amadeo
View profile
Isabel Wassink
View profile
Javier Millán Acosta
View profile
Tooba Abbassi-Daloii
View profile
ElenaDR
View profileCommunity Editors
Interested in a focused subset of pathways, for example relating to a disease or model organism? Join or create a WikiPathways Community and organize your own community practices and events. Here is a list of communities and lead editors and points of contact:
Adverse Outcome Pathways The Adverse Outcome Pathway Community is created to highlight the molecular basis of Adverse Outcome Pathways.
COVID-19 Molecular mechanisms of COVID-19
CPTAC The CPTAC Community highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).
Daphnia The Daphnia Community is set up for collaboration on getting knowledge together about the biological processes in the Daphnia magna species.
Diseases The Disease Community highlights WikiPathways content related to human disease, and is designed as a central organizing point for exploring, curating and expanding the collection of disease pathways.
ExRNA The ExRNA Community highlights pathway content relevant to the extracellular RNA research community.
Inherited Metabolic Disorders (IMD) Pathways The IMD Community is set up to give an overview of all Inherited Metabolic Disorders (IMDs), also known as Inborn Errors of Metabolism (IEM).
Lipids and LIPID MAPS This community is set up to coordinate the development of lipid pathways and gather the community interested in interactive lipid pathways. Lipids serve several important biological purposes, such as providing membrane structure, and signalling.
Micronutrients The Micronutrient Community highlights pathway content relevant to the micronutrient research community.
Nanomaterials Pathways The Nanomaterials Community serves the interest of nano systems biology research by facilitating community-based annotation of biological pathways related to nanosafety.
PancCanNet The PancCanNet Community highlights pathway content relevant to the pancreatic cancer research community.
Rare Diseases The Rare Disease Community highlights WikiPathways content related to rare genetic human diseases, and is designed as a central organizing point for exploring, curating and expanding the collection of rare disease pathways.
Reactome The Reactome portal can be found at https://classic.wikipathways.org/index.php/Portal:Reactome
Renal Genomics Pathways The Renal Genomics Community highlights WikiPathways content related to renal biology and disease
Skeletal Dysplasia The Skeletal Dysplasia Community was initiated with the goal to create Wikipathways diagrams for all known skeletal dysplasia genes.
WormBase The WormBase Community highlights pathway content maintained by WormBase and the Worm Community. WormBase is an international consortium of biologists and computer scientists dedicated to providing the research community with accurate, current, accessible information concerning the genetics, genomics and biology of C. elegans and related nematodes.
Developers
The WikiPathways project is 100% open source. Dive under the hood to review and contribute to the code base.
Founders
Back in 2007, members of the Conklin (Gladstone Institutes, CA, USA) and Evelo (Univ. Maastrict, NL) labs decided to collaborate on a new type of pathway database. Read all about it in Pico AR, et al. PLoS Biol. 2008.